Brawn Biotech Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 530207

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.94%
  • Mutual funds0.35%
  • Public46.71%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 52.94% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.00% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.35% in Jun 2026 qtr

All shareholding details →

Shareholding Trend (Promoter/FII/DII %, real filed periods only)

HolderJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Latest change
Promoter 52.94%52.94%53.39%53.66%53.66%53.66%53.64%53.64% 0.00 pp
FII 0.00%0.00%0.00%————— 0.00 pp
DII 0.35%0.35%0.35%0.35%0.35%0.35%0.35%0.35% 0.00 pp
Mutual funds (within DII) 0.35%0.35%0.35%0.35%0.35%0.35%0.35%0.35% 0.00 pp
Public (non-institutional) 46.71%46.71%46.26%————— 0.00 pp

Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).

Shareholding Pattern (latest quarter)

Category% holdingShareholders
Grand Total 100.0000 3284
(A) Promoter & Promoter Group 52.9400 21
(B) Public 47.0600 3263
(C1) Shares underlying DRs 0.0000 0
(C) Non Promoter-Non Public 0.0000 0
(C2) Shares held by Employee Trust 0.0000 0

Named Shareholders

Data unavailable.

Related